CN203763590U - Self-controlled direct-action neural analgesia system - Google Patents
Self-controlled direct-action neural analgesia system Download PDFInfo
- Publication number
- CN203763590U CN203763590U CN201420117723.5U CN201420117723U CN203763590U CN 203763590 U CN203763590 U CN 203763590U CN 201420117723 U CN201420117723 U CN 201420117723U CN 203763590 U CN203763590 U CN 203763590U
- Authority
- CN
- China
- Prior art keywords
- analgesia system
- self
- neural
- analgesia
- controlled direct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model relates to a self-controlled direct-action neural analgesia system. The self-controlled direct-action neural analgesia system comprises a power source, an upper end portion of a transfusion box and a lower end portion of the transfusion box; the power is connected with a mask type on-off controller and a micro electric rod; an injector is arranged at the top end of the micro electric rod; a through hole is formed at the top end of the lower end portion of the transfusion box and an indwelling catheter is arranged in the through hole. The self-controlled direct-action neural analgesia system is compact in design, small in volume, convenient to use, and suitable for carrying about; the fittings of the self-controlled direct-action neural analgesia system have mature products in the market, and thus do not need to be re-developed and are easy to assemble.
Description
Technical field
This utility model relates to the neural analgesia system of a kind of autocontrol direct effect.
Background technology
This utility model belongs to technical field of medical instruments, relates to analgesia field (comprising the pain that all kinds of Postoperative analgesias and chronic disease cause).Current like product on the market roughly has two classes: a class is to utilize the electronic analgesia pump of Fundamentals of Mono-Chip Computers design, and function is complete, but button is many, complicated operation, and apparatus assembly is complicated, involves great expense.If generating program mistake can have serious consequences, even fatal, during use, need change consumptive material, and consumptive material price is high, be difficult to be widely used in clinical, be that vast pain patients solves painful.Another kind of is disposable analgesia pump, take the mechanical elastic of gravity or silicon capsule as power drive administration, easy to use, but exists adjustability poor, can not often have the full phenomenon of analgesia according to the administration as required of the difference of individual patient, and price is also more expensive simultaneously.And the said goods is generally limited to intravenously administrable, drug use amount is large, and side effect is many, and analgesic effect is not good.
Utility model content
The purpose of this utility model is to provide the neural analgesia system of a kind of autocontrol direct effect, to overcome prior art above shortcomings.
The purpose of this utility model is to be achieved through the following technical solutions:
The neural analgesia system of a kind of autocontrol direct effect, comprise the upper end of power supply, fusion case and the bottom of fusion case, described power supply is connected with facial film formula switch controller and micro electric lever, the top of described micro electric lever is provided with syringe, the top of the bottom of described fusion case is provided with through hole, in described through hole, is provided with inlying catheter.
Further, the upper surface of the upper end of described fusion case is provided with some control buttons.
Further, the upper surface of the bottom of described fusion case is provided with transparent windows.
Further, described syringe is provided with the standard specifications of 5ml, 10ml and 50ml.
The beneficial effects of the utility model are: the neural analgesia of described autocontrol direct effect system design is compact, and volume is small and exquisite, easy to use, is applicable to carrying.The accessory of this product is having ripe product on the market, does not need again to develop, and be easy to assembling, and syringe is provided with the standard specifications of 5ml, 10ml, 50ml, does not need to pay in addition expensive consumptive material expense while using this product.Described analgesia system can directly act on the nerve of domination afflicted areas, accomplish from source pain relieving, and drug use amount still less, and analgesia time is longer, safety and reliability.
Accompanying drawing explanation
With reference to the accompanying drawings this utility model is described in further detail below.
Fig. 1 is the decomposition texture schematic diagram of the neural analgesia system of autocontrol direct effect described in this utility model embodiment.
In figure:
1, power supply; 2, the upper end of fusion case; 3, the bottom of fusion case; 4, facial film formula switch controller; 5, micro electric lever; 6, syringe; 7, through hole; 8, inlying catheter; 9, transparent windows.
The specific embodiment
As shown in Figure 1, the neural analgesia system of a kind of autocontrol direct effect described in this utility model embodiment, comprise the upper end 2 of power supply 1, fusion case and the bottom 3 of fusion case, described power supply 1 is connected with facial film formula switch controller 4 and micro electric lever 5, the top of described micro electric lever 5 is provided with syringe 6, the top of the bottom 3 of described fusion case is provided with through hole 7, is provided with inlying catheter 8 in described through hole.The upper surface of the upper end 2 of described fusion case is provided with some dry control buttons, comprises " opening " (opening equipment), " pass " (close and establish), "+" (transfusion speed is accelerated), "-" (transfusion speed is slowed down) button.
The upper surface of the bottom 3 of described fusion case is provided with transparent windows 9, sees through the scale that transparent windows 9 can be seen injection in syringe clearly.Described syringe 6 is provided with the standard specifications of 5ml, 10ml and 50ml, changes back and forth syringe 6 when standard specifications being set avoiding using.
This utility model can be used in many places analgesia, such as: canalis sacralis is kept somewhere analgesia epidural indwelling analgesia, brachial plexus nerve is kept somewhere analgesia, the other indwelling analgesia of femoral nerve etc.During concrete use, anaesthetist or doctor are placed in inlying catheter near the nerve root of domination afflicted areas, after keeping somewhere successfully, inlying catheter are connected to the syringe that installs medicinal liquid that is placed in fusion case the inside.Then, turn on the power switch, the electric energy of power supply will be converted into the kinetic energy that micro electric lever moves up and down, the medicinal liquid of injector-actuated the inside.Switch controller can regulate the size of electric current, and then controls the speed of micro electric lever, adjusts the speed of input.
This utility model is not limited to above-mentioned preferred forms; anyone can draw other various forms of products under enlightenment of the present utility model; no matter but do any variation in its shape or structure; every have identical with a application or akin technical scheme, within all dropping on protection domain of the present utility model.
Claims (3)
1. the neural analgesia system of an autocontrol direct effect, comprise the upper end (2) of power supply (1), fusion case and the bottom (3) of fusion case, it is characterized in that: described power supply (1) is connected with facial film formula switch controller (4) and micro electric lever (5), the top of described micro electric lever (5) is provided with syringe (6), the top of the bottom of described fusion case (3) is provided with through hole (7), is provided with inlying catheter (8) in described through hole (7).
2. the neural analgesia system of autocontrol direct effect according to claim 1, is characterized in that: the upper surface of the upper end of described fusion case (2) is provided with some control buttons.
3. the neural analgesia system of autocontrol direct effect according to claim 2, is characterized in that: the upper surface of the bottom of described fusion case (3) is provided with transparent windows (9).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420117723.5U CN203763590U (en) | 2014-03-14 | 2014-03-14 | Self-controlled direct-action neural analgesia system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420117723.5U CN203763590U (en) | 2014-03-14 | 2014-03-14 | Self-controlled direct-action neural analgesia system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203763590U true CN203763590U (en) | 2014-08-13 |
Family
ID=51280846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420117723.5U Expired - Fee Related CN203763590U (en) | 2014-03-14 | 2014-03-14 | Self-controlled direct-action neural analgesia system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203763590U (en) |
-
2014
- 2014-03-14 CN CN201420117723.5U patent/CN203763590U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN204684343U (en) | A kind of gas-tight alveolitoid transfusion device | |
| CN203763590U (en) | Self-controlled direct-action neural analgesia system | |
| RU98920U1 (en) | SYSTEM FOR REPEATED SCREEN INTRODUCTION OF SOLUTION OF MEDICINES | |
| CN203971079U (en) | Disconnection-preventing syringe | |
| CN101912644A (en) | Intelligent patient-controlled analgesia pump | |
| CN209713874U (en) | A kind of medical chemotherapy chemicals dosing plant | |
| CN201157547Y (en) | Fungi-proof infusion bottle cover | |
| CN207168792U (en) | Insulin injection pen | |
| CN201642937U (en) | Nursing dispensing appliance | |
| CN204815130U (en) | Electron infusion pump | |
| CN110368554A (en) | A kind of safety-type transfusion flow regulator | |
| CN205108563U (en) | Medical electron automatic pump | |
| CN208927267U (en) | A kind of endocrine system disease injection auxiliary device | |
| US10744271B2 (en) | Medicine delivery device | |
| CN101987212A (en) | Split medical electronic infusion pump | |
| CN201150693Y (en) | Dosage needle | |
| CN202822323U (en) | Automatic infusion device | |
| CN202892637U (en) | Infant anus pushing-injection machine | |
| CN201719622U (en) | Medicine pouring pump without transferring liquid | |
| CN201189330Y (en) | Bottle-block side-port puncture needle transfusion device | |
| CN201510585U (en) | Novel infusion apparatus | |
| CN203777425U (en) | Disposable small dose injection needle packaged with solution | |
| CN2296208Y (en) | Disposable transfusion system | |
| CN206630969U (en) | A kind of disposable syringe | |
| CN206687975U (en) | Safety-type medical vein syringe controlling organization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140813 Termination date: 20150314 |
|
| EXPY | Termination of patent right or utility model |